MENU
XGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Exagen (XGN) Ownership - Who owns Exagen?
Profile
Industry
N/A
Address
1261 Liberty Way
Phone
+1 760 560-1501
Employees
179
Web
https://www.exagen.com
Details
Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
27.06M
P/E Ratio
N/A
Total Cash
36.49M
Projected Growth
N/A
Total Debt
23.72M
Revenue
52.55M
Risk (Beta)
1.60
Dividend Yield
N/A
Total Cash/Share
2.12
Total Debt/Equity
N/A
Revenue/Share
2.97 USD as % of share price
Fundamentals
XGN
Capitalization
27.1M
P/E Ratio
N/A
Risk (Beta)
1.60
Dividend Yield
N/A
Total Cash
36.5M
Total Cash/Share
2.12
Total Debt
23.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.97%
Revenue
52.5M
ROE
N/A
Book Value
22.7M
P/B Ratio
1.19
Cash Flow
N/A
Earnings
-1.34
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
17K
Current Ratio
4.02
Current Revenue Per Employee
76899.44
Dividends Per Share - Security
N/A
EBITDA
-19.15M
Float
N/A
Float - Current
N/A
Gross Income Margin
59.17
Revenue To Assets
-33.09
Shares Held By Institutions
14.8M
Shares Outstanding - Current
17.2M
Total Liabilities
34.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
38.191
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases
Industry MedicalSpecialties
Profile
Fundamentals
Details
Industry
N/A
Address
1261 Liberty Way
Phone
+1 760 560-1501
Employees
179
Web
https://www.exagen.com